{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T15:14:45Z","timestamp":1648998885201},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf01738152","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T06:16:10Z","timestamp":1118643370000},"page":"967-977","source":"Crossref","is-referenced-by-count":1,"title":["Medikament\u00f6se Behandlung der chronisch verlaufenden Glomerulonephritiden: Pro"],"prefix":"10.1007","volume":"63","author":[{"given":"K.","family":"K\u00fchn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Brodehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Helmchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01738152_CR1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/BF01738153","volume":"63","author":"K Andrassy","year":"1985","unstructured":"Andrassy K, Waldherr R, Ritz E (1985) Medikament\u00f6se Behandlung der chronisch verlaufenden Glomerulonephritiden: Contra. Klin Wochenschr 63:978\u2013987","journal-title":"Klin Wochenschr"},{"key":"BF01738152_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00442096","volume":"135","author":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","year":"1981","unstructured":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie (1981) Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. Eur J Pediatr 135:229\u2013237","journal-title":"Eur J Pediatr"},{"key":"BF01738152_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJM198202253060803","volume":"306","author":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","year":"1982","unstructured":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451\u2013454","journal-title":"N Engl J Med"},{"key":"BF01738152_CR4","first-page":"470","volume-title":"The natural and treatment history of glomerular diseases in children","author":"HL Barnett","year":"1976","unstructured":"Barnett HL (1976) The natural and treatment history of glomerular diseases in children. Proc 6th Int Congress of Nephrol, Karger, Basel, pp 470\u2013485"},{"key":"BF01738152_CR5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0002-9343(80)90373-3","volume":"68","author":"CH Barton","year":"1980","unstructured":"Barton CH, Vaziri ND, Spear GS (1980) Nephrotic syndrome associated with adeno-carcinoma of the breast. Am J Med 68:308\u2013312","journal-title":"Am J Med"},{"key":"BF01738152_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","volume":"3","author":"DAK Black","year":"1970","unstructured":"Black DAK, Rose G, Brewer DB (1970) Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J 3:421\u2013426","journal-title":"Br Med J"},{"key":"BF01738152_CR7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM198207223070403","volume":"307","author":"BM Brenner","year":"1982","unstructured":"Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 307:652\u2013659","journal-title":"N Engl J Med"},{"key":"BF01738152_CR8","first-page":"1233","volume-title":"Mechanisms of progression of renal disease","author":"BM Brenner","year":"1984","unstructured":"Brenner BM, Meyer TW (1984) Mechanisms of progression of renal disease. Proc 9th Int Congress of Nephrol, Springer, New York Heidelberg, Vol II, pp 1233\u20131246"},{"key":"BF01738152_CR9","doi-asserted-by":"crossref","unstructured":"Brodehl J, Hoyer PF (1985) Cyclosporin A treatment of idiopathic nephrotic syndrome in children (minimal disease and focal segmental glomerulosclerosis). Int Workshop on cyclosporin in auto-immune diseases, Basel, 1985 (im Druck)","DOI":"10.1007\/978-3-642-70607-3_64"},{"key":"BF01738152_CR10","first-page":"1445","volume-title":"Treatment of glomerular diseases. Treatment of glomerulonephritis based on knowledge of its pathogenesis","author":"JS Cameron","year":"1984","unstructured":"Cameron JS (1984) Treatment of glomerular diseases. Treatment of glomerulonephritis based on knowledge of its pathogenesis. Proc 9th Int Congress of Nephrol, Springer, New York Heidelberg, Vol II, pp 1445\u20131463"},{"key":"BF01738152_CR11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.CIR.70.4.523","volume":"70","author":"PJ Cannon","year":"1984","unstructured":"Cannon PJ (1984) Eicosanoids and the blood vessel wall. Circulation 70:523\u2013528","journal-title":"Circulation"},{"key":"BF01738152_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-99-1-1","volume":"99","author":"S Carette","year":"1983","unstructured":"Carette S, Klippel JH, Decker JL, Austin HA, Plotz PH, Steinberg AD, Balow JE (1983) Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow up. Ann Intern Med 99:1\u20138","journal-title":"Ann Intern Med"},{"key":"BF01738152_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(85)92090-2","volume":"I","author":"S Cats","year":"1985","unstructured":"Cats S, Terasaki PI, Perdue S, Mickey MR (1985) Preferential effectiveness of cyclosporin in patients receiving kidney transplants after glomerulonephritis. Lancet I:490\u2013491","journal-title":"Lancet"},{"key":"BF01738152_CR14","unstructured":"Cattran D, Cardella C, Charron J, Roscoe E, Bear R, Corey P (1984) Results of a controlled trial of alternate day prednisone in idiopathic membranous glomerulopathy. 9th Int Congress of Nephrology, 74A (Abstract)"},{"key":"BF01738152_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1985.28","volume":"27","author":"D Cattran","year":"1985","unstructured":"Cattran D, Cardella C, Roscoe E, Charron J, Rance PC, Ritchie SM, Corey P (1985) Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27:436\u2013441","journal-title":"Kidney Int"},{"key":"BF01738152_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198402023100502","volume":"310","author":"G Ciabattoni","year":"1984","unstructured":"Ciabattoni G, Cinotti G, Pierucci A, Simonetti B, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C (1984) Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 310:279\u2013283","journal-title":"N Engl J Med"},{"key":"BF01738152_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000409748","volume":"40","author":"AR Clarkson","year":"1984","unstructured":"Clarkson AR, Woodroffe AJ (1984) Therapeutic perspectives in mesangial IgA-nephropathy. Contr Nephrol 40:187\u2013194","journal-title":"Contr Nephrol"},{"key":"BF01738152_CR18","first-page":"336","volume-title":"Minimal change nephrosis in adults","author":"CH Coggins","year":"1981","unstructured":"Coggins CH (1981) Minimal change nephrosis in adults. Proc 8th Int Congress of Nephrol, Basel, Karger, pp 336\u2013344"},{"key":"BF01738152_CR19","first-page":"1436","volume-title":"Primary glomerular disease (chapter 26)","author":"C Coggins","year":"1981","unstructured":"Coggins C, Churg I, Spargo B, Cotran R, Burkholder P, Rosen S, Pinn V, Glassock RJ (1981) US Cooperative Study of Adult Nephrotic Syndrome. Unpublished observations. In: Primary glomerular disease (chapter 26). In: Brenner BM, Rector FC (eds) The Kidney, WB Saunders, Philadelphia London Toronto, p 1436"},{"key":"BF01738152_CR20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM197912133012401","volume":"301","author":"Collaborative study of the adult idiopathic nephrotic syndrome","year":"1979","unstructured":"Collaborative study of the adult idiopathic nephrotic syndrome (1979) A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301:1301\u20131306","journal-title":"N Engl J Med"},{"key":"BF01738152_CR21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/0002-9343(74)90176-4","volume":"57","author":"WG Couser","year":"1974","unstructured":"Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ (1974) Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med 57:962\u2013970","journal-title":"Am J Med"},{"key":"BF01738152_CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000407068","volume":"33","author":"JV Donadio","year":"1982","unstructured":"Donadio JV (1982) Primary glomerular disease: To treat or not to treat? Contr Nephrol 33:86\u2013103","journal-title":"Contr Nephrol"},{"key":"BF01738152_CR23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198405313102203","volume":"310","author":"JV Donadio","year":"1984","unstructured":"Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH (1984) Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med 310:1421\u20131426","journal-title":"N Engl J Med"},{"key":"BF01738152_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.1974.129","volume":"6","author":"JV Donadio","year":"1974","unstructured":"Donadio JV, Holley KE, Anderson CF, Taylor WF (1974) Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int 6:431\u2013439","journal-title":"Kidney Int"},{"key":"BF01738152_CR25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJM197811232992102","volume":"299","author":"JV Donadio","year":"1978","unstructured":"Donadio JV, Holley KE, Ferguson RH, Ilstrup DM (1978) Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299:1151\u20131155","journal-title":"N Engl J Med"},{"key":"BF01738152_CR26","first-page":"137","volume":"27","author":"AJ Donker","year":"1985","unstructured":"Donker AJ, Rosman JB, Piers-Becht TP, Sluiter WJ (1985) Effect of protein restriction in chronic renal insufficiency: A prospective randomized trial. Kidney Int 27:137 (Abstract)","journal-title":"Kidney Int"},{"key":"BF01738152_CR27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/BF01715845","volume":"60","author":"IC Fr\u00f6lich","year":"1982","unstructured":"Fr\u00f6lich IC, Fejes-Toth G (1982) Renal prostaglandins. Klin Wochenschr 60:1155\u20131164","journal-title":"Klin Wochenschr"},{"key":"BF01738152_CR28","first-page":"180","volume":"10","author":"P Futrakul","year":"1978","unstructured":"Futrakul P, Poshyachinda M, Mitrakul C (1978) Focal sclerosing glomerulonephritis: A kinetic evaluation of hemostasis and the effect of anticoagulant therapy: A controlled study. Clin Nephrol 10:180\u2013186","journal-title":"Clin Nephrol"},{"key":"BF01738152_CR29","first-page":"109","volume":"22","author":"DF Geary","year":"1984","unstructured":"Geary DF, Farine M, Thorner P, Baumal R (1984) Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: A reappraisal. Clin Nephrol 22:109\u2013113","journal-title":"Clin Nephrol"},{"key":"BF01738152_CR30","first-page":"196","volume-title":"Glomerulonephritis","author":"German Glomerulonephritis Research Group","year":"1976","unstructured":"German Glomerulonephritis Research Group (1976) A controlled multicenter trial of cyclophosphamide and indomethacin in chronic glomerulonephritis. In: Kluthe R, Vogt A, Batsford SR (eds) Glomerulonephritis. Georg Thieme, Stuttgart, pp 196\u2013201"},{"key":"BF01738152_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000166491","volume":"1","author":"RJ Glassock","year":"1981","unstructured":"Glassock RJ, Goldstein DA, Finander P, Koss M, Kitridou R, Border W (1981) Glomerulonephritis in systemic lupus erythematosus. Am J Nephrol 1:53\u201367","journal-title":"Am J Nephrol"},{"key":"BF01738152_CR32","first-page":"634","volume-title":"Minimal change disease, mesangioproliferative glomerulonephritis and focal sclerosis: Individual entities or a spectrum of disease?","author":"R Habib","year":"1984","unstructured":"Habib R, Churg J, Bernstein J, Cameron JS, Cohen AH, Gagnadoux MF, Lewis EJ (1984) Minimal change disease, mesangioproliferative glomerulonephritis and focal sclerosis: Individual entities or a spectrum of disease? Proc 9th Int Congress of Nephrol, Springer, New York Heidelberg, Vol I, pp 634\u2013644"},{"key":"BF01738152_CR33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(84)92355-9","volume":"I","author":"T Hamazaki","year":"1984","unstructured":"Hamazaki T, Tateno S, Shishido H (1984) Eicosapentaenoic acid and IgA-nephropathy. Lancet I:1017\u20131018","journal-title":"Lancet"},{"key":"BF01738152_CR34","first-page":"141","volume":"27","author":"FN Hutchison","year":"1985","unstructured":"Hutchison FN, Gambertoglio J, Jiminez I, Jones H (1985) Effect of reduced dietary protein intake on albumin homeostasis and albuminuria in man. Kidney Int. 27:141 (Abstract)","journal-title":"Kidney Int."},{"key":"BF01738152_CR35","first-page":"214","volume":"44","author":"H Ito","year":"1981","unstructured":"Ito H, Hattoni S, Matusda I, Amamiga S, Hajikano H, Yoshizawa H, Migakawa Y, Mayumi M (1981) Hepatitis B e antigen-mediated membranous glomerulonephritis. Correlation of ultrastructural changes with HBeAg in the serum and glomeruli. Lab Invest 44:214\u2013220","journal-title":"Lab Invest"},{"key":"BF01738152_CR36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmj.290.6462.96","volume":"290","author":"P Kincaid-Smith","year":"1985","unstructured":"Kincaid-Smith P (1985) Mesangial IgA-nephropathy. Brit Med J 290:96\u201397","journal-title":"Brit Med J"},{"key":"BF01738152_CR37","first-page":"250","volume-title":"Uraemia: Pathogenesis, Diagnosis and Treatment","author":"R Kluthe","year":"1971","unstructured":"Kluthe R, Oechslin D, Quirin H, Jesdinsky HJ (1971) Six years experience with a special low protein diet. In: Kluthe R, Berlyne G, Burton B (eds) Uraemia: Pathogenesis, Diagnosis and Treatment. Thieme, Stuttgart, pp 250\u2013257"},{"key":"BF01738152_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000409942","volume":"43","author":"K K\u00fchn","year":"1984","unstructured":"K\u00fchn K, Menninger H (1984) Is renal biopsy overused in patients with systemic lupus erythematosus? Contr Nephrol 43:45\u201350","journal-title":"Contr Nephrol"},{"key":"BF01738152_CR39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000181999","volume":"26","author":"M Levy","year":"1980","unstructured":"Levy M, Kleinknecht C (1980) Membranous glomerulonephritis and hepatitis B infection. Nephron 26:259\u2013265","journal-title":"Nephron"},{"key":"BF01738152_CR40","first-page":"1437","volume-title":"Are randomized trials in kidney disease worthwhile?","author":"EJ Lewis","year":"1984","unstructured":"Lewis EJ, Coggins CH, West CD, Spitzer A, Zimmermann SW, Lachin J, Winslade W, Cattran DC (1984) Are randomized trials in kidney disease worthwhile? Proc 9th Int Congress of Nephrol, Springer, New York Heidelberg, Vol II, pp 1437\u20131444"},{"key":"BF01738152_CR41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-83-1-8","volume":"83","author":"F Llach","year":"1975","unstructured":"Llach F, Koffler A, Massry SG (1975) On the incidence of renal vein thrombosis and nephrotic syndrome. Ann Intern Med 83:8\u201317","journal-title":"Ann Intern Med"},{"key":"BF01738152_CR42","first-page":"117","volume":"13","author":"PT McEnery","year":"1980","unstructured":"McEnery PT, McAdams AJ, West CD (1980) Membranoproliferative glomerulonephritis: improved survival with alternate-day prednisone therapy. Clin Nephrol 13:117\u2013124","journal-title":"Clin Nephrol"},{"key":"BF01738152_CR43","first-page":"149","volume-title":"Glomerulonephritis","author":"P Michielsen","year":"1976","unstructured":"Michielsen P, Vanrenterghem Y, Roels L (1976) Treatment of chronic glomerulonephritis with indomethacin. In: Kluthe R, Vogt A, Batsford SR (eds) Glomerulonephritis. Georg Thieme Publishers, Stuttgart, pp 149\u2013153"},{"key":"BF01738152_CR44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI111391","volume":"74","author":"A Naray-Fejes-Toth","year":"1984","unstructured":"Naray-Fejes-Toth A, Fejes-Toth G, Fischer C, Fr\u00f6lich JC (1984) Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest 74:120\u2013123","journal-title":"J Clin Invest"},{"key":"BF01738152_CR45","first-page":"687","volume":"I","author":"T Niwa","year":"1982","unstructured":"Niwa T, Maeda K, Naotsuka Y, Asada H, Kobayashi S, Yokoyama M, Kawaguchi S, Shibata M (1982) Improvement of renal function with prostaglandin E1 infusion in patients with chronic renal disease. Lancet I:687","journal-title":"Lancet"},{"key":"BF01738152_CR46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9343(79)90486-8","volume":"66","author":"LH Noel","year":"1979","unstructured":"Noel LH, Zanetti M, Droz D, Barbanel C (1979) Long-term prognosis of idiopathic membranous glomerulonephritis: study of 116 untreated patients. Am J Med 66:82\u201390","journal-title":"Am J Med"},{"key":"BF01738152_CR47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.1985.46","volume":"27","author":"L Oldrizzi","year":"1985","unstructured":"Oldrizzi L, Rugiu C, Valvo E, Lupo A, Loschiavo C, Lammaro L, Tessitore N, Fabris A, Panzetta G, Maschio G (1985) Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet. Kidney Int 27:553\u2013557","journal-title":"Kidney Int"},{"key":"BF01738152_CR48","first-page":"16","volume":"201","author":"C Ponticelli","year":"1982","unstructured":"Ponticelli C, Zucchelli P, Banfi G, Cagnoli L, Scalia P, Pasquali S, Imbasciati E (1982) Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methyl-prednisolone. Q J Med 201:16\u201324","journal-title":"Q J Med"},{"key":"BF01738152_CR49","first-page":"717","volume":"19","author":"C Ponticelli","year":"1982","unstructured":"Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F (1982) Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy. Proc EDTA 19:717\u2013723","journal-title":"Proc EDTA"},{"key":"BF01738152_CR50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI110288","volume":"68","author":"JD Pricket","year":"1981","unstructured":"Pricket JD, Robinson DR, Steinberg AD (1981) Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB \u00d7 NZW F1 mice. J Clin Invest 68:556\u2013559","journal-title":"J Clin Invest"},{"key":"BF01738152_CR51","first-page":"507","volume-title":"Clinical aspects of immunology","author":"AJ Rees","year":"1982","unstructured":"Rees AJ, Lockwood CM (1982) Immunosuppressive drugs in clinical practice. In: Lachmann TJ, Peters DK (eds) Clinical aspects of immunology. Blackwell, Oxford, pp 507\u2013564"},{"key":"BF01738152_CR52","first-page":"423","volume":"II","author":"Report of the International Study of Kidney Disease in Children","year":"1974","unstructured":"Report of the International Study of Kidney Disease in Children (1974) Prospective, controlled trial of cyclophosphamid therapy in children with the nephrotic syndrome. Lancet II:423\u2013427","journal-title":"Lancet"},{"key":"BF01738152_CR53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","volume":"98","author":"Report of the International Study of Kidney Disease in Children","year":"1981","unstructured":"Report of the International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561\u2013564","journal-title":"J Pediatr"},{"key":"BF01738152_CR54","unstructured":"Report of the International Study of Kidney Disease in Children (1981) Alternate-day steroid therapy in membrano-proliferative glomerulonephritis: a randomized controlled clinical trial. 14th Ann Meet of Am Soc Nephrol 23A (Abstract)"},{"key":"BF01738152_CR55","first-page":"174","volume-title":"Glomerulonephritis","author":"G Rose","year":"1976","unstructured":"Rose G (1976) Medical Research Concil Trials. In: Kluthe R, Vogt A, Batsford SR (eds) Glomerulonephritis. Georg Thieme Publishers, Stuttgart, pp 174\u2013182"},{"key":"BF01738152_CR56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000183113","volume":"36","author":"H Saito","year":"1984","unstructured":"Saito H, Ideura T, Takeuchi J (1984) Effects of a selective thromboxane A2 synthetase inhibitor on immune complex glomerulonephritis. Nephron 36:38\u201345","journal-title":"Nephron"},{"key":"BF01738152_CR57","first-page":"264","volume-title":"Vascular permeability factor and other lymphokines in nephrotic syndrome","author":"AT Sobel","year":"1984","unstructured":"Sobel AT, Heslan JT, Branellec A, Lagrue G (1984) Vascular permeability factor and other lymphokines in nephrotic syndrome. Proc 6th Int Symp of Pediatic Nephrol, Springer, Berlin New York, pp 264\u2013267"},{"key":"BF01738152_CR58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ki.1984.181","volume":"26","author":"TB Strom","year":"1984","unstructured":"Strom TB (1984) Immunsuppressive agents in renal transplantation. Kidney Int 26:353\u2013365","journal-title":"Kidney Int"},{"key":"BF01738152_CR59","first-page":"345","volume-title":"A prospective randomized trial in the use of cyclophosphamide, dipyridamole, and warfarin in membranous and mesangio-capillary glomerulonephritis","author":"DJ Tiller","year":"1981","unstructured":"Tiller DJ, Clarkson AR, Mathew T, Thompson N, Row G, Lauer C, Hobbs J, Semour A (1981) A prospective randomized trial in the use of cyclophosphamide, dipyridamole, and warfarin in membranous and mesangio-capillary glomerulonephritis. Proc 8th Int Congress of Nephrol, Karger, Basel, pp 345\u2013351"},{"key":"BF01738152_CR60","unstructured":"Trompeter RS: Unpublished observations"},{"key":"BF01738152_CR61","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(81)92348-5","volume":"I","author":"RS Trompeter","year":"1981","unstructured":"Trompeter RS, Evans PR, Barratt TM (1981) Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet I:1177\u20131179","journal-title":"Lancet"},{"key":"BF01738152_CR62","first-page":"659","volume":"16","author":"Y Vanrenterghem","year":"1979","unstructured":"Vanrenterghem Y, Roels L, van Damme B, Michielsen P (1979) Influence of indomethacin treatment on the spontaneous glomerulosclerosis of the rat. Kidney Int 16:659 (Abstract)","journal-title":"Kidney Int"},{"key":"BF01738152_CR63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000409941","volume":"43","author":"R Waldherr","year":"1984","unstructured":"Waldherr R (1984) Predictive value of renal biopsy in lupus nephritis. Contr Nephrol 43:36\u201344","journal-title":"Contr Nephrol"},{"key":"BF01738152_CR64","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/0002-9343(83)90864-1","volume":"75","author":"SW Zimmermann","year":"1983","unstructured":"Zimmermann SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U (1983) Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. Am J Med 75:920\u2013927","journal-title":"Am J Med"},{"key":"BF01738152_CR65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000409746","volume":"40","author":"P Zucchelli","year":"1984","unstructured":"Zucchelli P, Zuccala A, Santoro A, Esposti ED, Sturani A, Chiarini C (1984) Characteristics of hypertension in primary IgA-glomerulonephritis. Contr Nephrol 40:174\u2013181","journal-title":"Contr Nephrol"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01738152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:01:01Z","timestamp":1586282461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01738152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":65,"journal-issue":{"issue":"18","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF01738152"],"URL":"https:\/\/doi.org\/10.1007\/bf01738152","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}